Transplant-associated thrombotic microangiopathy: a rare but deadly complication post orthotopic heart transplantation
Jose Ruiz-Morales1
Maedeh Ganji2
Rohan Goswami1
1.Division of Advanced Heart Failure&Transplant Cardiology,Mayo Clinic,Jacksonville,Florida,USA2.Cardiology Department,University of Florida,Jacksonville,Florida,USA
摘要：Thrombotic microangiopathy (TMA) is po-tentially life-threatening condition causedby small-vessel microthrombi and is asso-ciated with schistocyte formation, low platelets and end-organ damage that may not be reversible.[1,2] As a life-threatening condition, TMA recognition in ho-spitalized patients after organ transplantation is key to improving survival. Transplant-associated TMA (TATMA) can occur after both solid organ or hema-topoietic stem cell transplantation and often mimics other disease processes such as thrombotic throm-bocytopenic purpura (TTP) with similar constella-tion of symptoms during presentation. We present a rare case of a patient with TATMA after orthotopic heart transplantation.
机标关键词：heartpostrareassociatedcomplicationdeadlymicroangiopathyorthotopic
论文发表日期：2022-06-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 485-486 )